Memorial Sloan Kettering Cancer Center Dept Oncology

New York, New York 90033

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Metastatic BRAF Mutant Melanoma, Locally Advanced or Metastatic NRAS Mutant Melanoma

Studies at this site

• A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma — Completed
• Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. — Stopped early